Pandemic Vaccines Bypass Genuine Safety Testing, Turning Population into Guinea Pigs

(NaturalNews by: Mike Adams) Emails and information circulating on the ‘net point to a rumor that the World Health Organization (WHO) has released a pandemic virus into the population via a “mock-up” vaccine. One story cites a WHO announcement Safety of pandemic vaccines which explains:

Also in Europe, some manufacturers have conducted advance studies using a so-called “mock-up” vaccine. Mock-up vaccines contain an active ingredient for an influenza virus that has not circulated recently in human populations and thus mimics the novelty of a pandemic virus. Such advance studies can greatly expedite regulatory approval.

Safety of pandemic vaccines
Pandemic (H1N1) 2009 briefing note 6
August 6th, 2009

EMEA mock-Up Vaccines Doc

The point of these “mock-up” vaccines is to allow vaccine manufacturers to gain regulatory approvals for “placeholder” vaccines in advance of a pandemic. Once a pandemic appears, the vaccine manufacturer can then replace the “mock-up” viral strain in the vaccine with the newly emerging in-the-wild pandemic viral strain, thus speeding the time to market for the new pandemic vaccine.

This process is explained in more detail in this EMEA (European Medicines Agency) It explains:

A mock-up pandemic influenza vaccine is a vaccine that mimics the future pandemic influenza vaccine in terms of its composition and manufacturing method. However, because the virus strain causing the pandemic is not known, the mock-up vaccine contains another flu strain instead. This is a strain that is not circulating in humans, and to which humans have not been exposed in the past. This enables the company to test its vaccine in preparation for any flu pandemic that may occur in the future, by carrying out studies with the mock-up vaccine that predict how people will react to the vaccine when the strain causing a pandemic is included.

There are two things I find quite concerning in this statement:

1. The viral strain chosen for this mock-up is one that is not currently circulating in humans. Thus, they are choosing a viral strain to which humans have no acquired immune defense.
2. These mock-up vaccines are tested on humans in order to “predict how people will react.” Thus, the drug companies are engaged in injecting people with viral fragments that have never been previously encountered by humans.

Obviously, if mistakes are made in the processing of these vaccines, causing live viruses to be injected (instead of sufficiently weakened viruses), this could result in the spread of that new virus among the human population. Thus, there is the possibility that this process could be used as vector through which infectious disease is spread, but it all depends on which virus is chosen for the mock-up vaccines.

And that’s never explained in any public documents that I could find. Where do the drug companies find these viruses to which humans have never been exposed? Are they getting them from military labs? Animal experiments? Are they specifically chosen to be similar to H1N1, or do they have a completely different protein configuration?

It is the selection of this viral strain that appears to be one of the most important factors in all this.

In any case, it’s clear that this mock-up process is pursued by vaccine manufacturers, not the WHO itself, so I disagree with any report that states the WHO itself released a pandemic virus into the population. The WHO is merely explaining what a mock-up vaccine is. They aren’t the ones manufacturing these mock-up vaccines or testing them on humans. That’s being done by the drug companies.